Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Apr 17, 2021 3:06am
123 Views
Post# 33016451

RE:RE:RE:RE:RE:RE:Information Circular posted

RE:RE:RE:RE:RE:RE:Information Circular posted

Insiders who own that little shares in their own company is a bad sign
and shows the market that they have no confidence in their approach of the pipeline. Why invest and take some risk while the Board isn't!!!????

Further, they showed disastrous marketing skills!!! While "shitty" companies could raise 100/200 M and more without warrants, they did an offering..............(fill in for yourself.....)!!! On top of that, while asking why they did not raise when the price was way higher, they said at that time they didn't need the money..........?????!!!!!! Foresight and clever for sure.......!

BUT we are here now and future looks promising, so we have to HOPE (again and again) especially for cancern patients !! 

So, good luck to all the people with good intentions!!

PS: bought again GLPG for 1/2 of what i want(CEO has many shares and they have 5B in cash) + a few stocks in oncology (we have to get rid of that devastating desease!!!!) 


Wino115
 - (4/16/2021 9:44:33 PM)
RE:RE:RE:RE:RE:Information Circular posted 
Frankly, it's atrocious how few shares the entire Board owns. Especailly given the huge dips over the last 2 years. As Canadapeit always complained, they really should be eating home cooking and be required to own a lot more than the tiny amount they do.  Another huge difference between the VC backed startups where managers and boards are massively aligned with their shareholders and THTX and many other Canadian companies. It's just a different mentality. Dawn should up the number of required shares by 4x and given them 12 months to conform.
<< Previous
Bullboard Posts
Next >>